Iodide

Iodide

SCHEMBL3754219

C=CC[P+](CC=C)(c1ccccc1)c1ccccc1.[I-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.39
HIF1A Q16665 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TSHR P16473 4/20 0.35
CASP3 P42574 1/20 0.33
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1072192 0.95 CYP2C19 (0.39) CYP2C19HIF1ASMN1; SMN2ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL19510269 0.95 CYP2C19 (0.39) CYP2C19HIF1ASMN1; SMN2ALDH1A1KDM4E
Iodide SCHEMBL1054412 0.81 HIF1A (0.50) CYP2C19HIF1ASMN1; SMN2ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL477383 0.76 HIF1A (0.50) CYP2C19HIF1ASMN1; SMN2ALDH1A1KDM4E
Bromide SCHEMBL161017 0.76 HIF1A (0.50) CYP2C19HIF1ASMN1; SMN2ALDH1A1KDM4E
Water SCHEMBL3422252 0.76 HIF1A (0.50) CYP2C19HIF1ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL3961571 0.74 CYP2C19 (0.38) CYP2C19HIF1ASMN1; SMN2ALDH1A1KDM4E
Perchlorate SCHEMBL11848103 0.71 HIF1A (0.44) CYP2C19HIF1ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL9180560 0.71 HIF1A (0.44) CYP2C19HIF1ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL8972925 0.71 HIF1A (0.44) CYP2C19HIF1ASMN1; SMN2ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604201-B2 Use of cyclovinyl phosphine/copper complexes as arylation catalysts CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2013-12-10 US disclosed
US-20100298569-A1 USE OF CYCLOVINYL PHOSPHINE/COPPER COMPLEXES AS ARYLATION CATALYSTS CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298569-A1 USE OF CYCLOVINYL PHOSPHINE/COPPER COMPLEXES AS ARYLATION CATALYSTS CPNE4, CBR3, DDT CYP2C19 873/4885HIF1A 3981/4885SMN1; SMN2 4303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.